Evaluation of tibolone effect on arterial resistance in postmenopausal women

References

• Lobo RA. Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol 1990;75\(Suppl 4):18S-25S, discussion 31S–5S
   Google Scholar
• Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardio-vascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325:756–62
   Google Scholar
• Sullivan JM. Atherosclerosis and estrogen replacement therapy. Int J Fertil Menopausal Stud 1994;(Suppl 1):28–35
   Google Scholar
• Coats A. Blood pressure and hypertension. In Stevenson J, ed. Hormone Replacement Therapy and the Cardiovascular System. Abingdon, UK: The Medicine Group, 1994:24–6
   Google Scholar
• Jackson S, Vyas S. A double-blind, placebo con-trolled study of postmenopausal oestrogen replacement therapy and carotid artery pulsa-tility index. Br J Obstet Gynaecol 1998;105: 408–12
   PubMedGoogle Scholar
• Ross LA, Alder EM. Tibolone and climacteric symptoms. Maturitas 1995;21:127–36
   PubMed Web of Science ®Google Scholar
• Riggs BL. Tibolone as an alternative to estrogen for the prevention of postmenopausal osteo-porosis in selected postmenopausal women [Editorial; Comment] [published erratum appears in J Clin Endocrinol Metab 1997;82: 181]. J Clin Endocrinol Metab 1996;81:2417–18
   PubMed Web of Science ®Google Scholar
• Rymer JM. The effects of tibolone. Gynecol Endocrinol 1998;12:213–20
   PubMed Web of Science ®Google Scholar
• Speroff L. Postmenopausal hormone therapy and breast cancer. Obstet Gynecol 1996;87 (Suppl 2):445–545
   Google Scholar
• Rymer J, Crook D, Sidhu M, Chapman M, Stevenson JC. Effects of tibolone on serum concentrations of lipoprotein( a) in postmeno-pausal women. Acta Endocrinol (Copenh ) 1993;128:259–62
   PubMedGoogle Scholar
• Palacios S. Tibolone: what does tissue specific activity mean? Maturitas 2001;37:159–65
   PubMed Web of Science ®Google Scholar
• Kloosterboer HJ. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001;76:231–8
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801–11
   PubMed Web of Science ®Google Scholar
• Meyer WJ, Jaffe R. Basic principles of Doppler ultrasonography. In Bolger EM, ed. Color Doppler Imaging in Obstetrics and Gynecology. New York: McGraw-Hill, 1992:1–16
   Google Scholar
• Pearson JD. Vasoactive substances. In Stevenson J, ed. Hormone Replacement Therapy and the Cardiovascular System. Abingdon, UK: The Medicine Group, 1994:27–9
   Google Scholar
• Beale CM, Collins P. The menopause and the cardiovascular system. Baillière's Clin Obstet Gynaecol 1996;10:483–513
   PubMed Web of Science ®Google Scholar
• Cerri GG, Molnar RJ, Vezozzo DCT. Principios básicos e instrumentação. In Cerri GG, ed. Doppler. São Paulo: Sarvier; 1996:3–16
   Google Scholar
• Kuhl H. Cardiovascular disease and estrogen replacement therapy — epidemiological data. In Rippert TH, Mueck OA, Ginsburg J, eds. Sex Steroids and the Cardiovascular System. Carnforth, UK: Parthenon Publishing, 1996: 97–109
   Google Scholar
• Cacciatore B, Paakkari I, Toivonen J, Tikkanen MJ, Ylikorkala 0. Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow. Obstet Gynecol 1998;92:563–8
   Google Scholar
• de Ziegler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: physiological effects of estradiol and progesterone. Fertil Steril 1991;55:775–9
   Google Scholar
• Penotti M, Farina M, Castiglioni E, et al. Alter-ation in the pulsatility index values of the internal carotid and middle cerebral arteries after suspen-sion of postmenopausal hormone replacement therapy: a randomized crossover study. Am J Obstet Gynecol 1996;175:606–11
   PubMed Web of Science ®Google Scholar
• Lau TK, Wan D, Yim SF, Sanderson JE, Haines CJ. Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmeno-pausal women. Fertil Steril 1998;70:284–8
   Google Scholar
• Feher MD, Cox A, Levy A, Mayne P, Lant AF. Short term blood pressure and metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes. Br J Obstet Gynaecol 1996;103:281–3
   Google Scholar
• Zandberg P, Peters JL, Demacker PN, Smit MJ, de Reeder EG, Meuleman DG. Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits. Arterioscler Thromb Vasc Biol 1998;18:1844–54
   PubMed Web of Science ®Google Scholar
• Lloyd G, McGing E, Cooper A, et al. A random-ised placebo controlled trial of the effects of tibolone on blood pressure and lipids in hyper-tensive women. J Hum Hypertens 2000;14: 99–104
   PubMed Web of Science ®Google Scholar
• Farish E, Barnes JF, Fletcher CD, Ekevall K, Calder A, Hart DM. Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen. Menopause 1999;6:98–104
   PubMed Web of Science ®Google Scholar
• Bourne T, Hillard TC, Whitehead MI, Crook D, Campbell S. Oestrogens, arterial status, and postmenopausal women. Lancet 1990;335: 1470–1
   Google Scholar
• Penotti M, Nencioni T, Gabrielli L, Farina M, Castiglioni E, Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replace-ment therapy. Am J Obstet Gynecol 1993; 169:1226–32
   PubMed Web of Science ®Google Scholar
• Hillard TC, Bourne TH, Whitehead MI, Crayford TB, Collins WP, Campbell S. Differen-tial effects of transdermal estradiol and sequen-tial progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992;58:959–63
   PubMed Web of Science ®Google Scholar
• Darj E, Bakos 0, Naessen T, Persson I. Ultra-sonographic blood flow measurement in the carotid arteries in postmenopausal women. Gynecol Obstet Invest 1997;47:20–5
   Google Scholar
• Lau TK, Chung TK, Haines CJ. A preliminary study on the effect of hormone replacement therapy on peripheral flow velocity in postmeno-pausal women. Maturitas 1997;26:53–6
   Google Scholar
• Hardiman P, Nihoyannopoulos P, Kicovic P, Ginsburg J. Cardiovascular effects of Org OD 14 — a new steroidal therapy for climacteric symptoms. Maturitas 1991;13:235–42
   PubMed Web of Science ®Google Scholar